• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗风险的床旁评估:新的梅奥诊所风险评分

Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores.

作者信息

Singh Mandeep, Rihal Charanjit S, Lennon Ryan J, Spertus John, Rumsfeld John S, Holmes David R

机构信息

Division of Cardiovascular Diseases, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

出版信息

Mayo Clin Proc. 2007 Jun;82(6):701-8. doi: 10.4065/82.6.701.

DOI:10.4065/82.6.701
PMID:17550750
Abstract

OBJECTIVE

To derive risk models for percutaneous coronary intervention (PCI) outcomes from clinical and laboratory variables available before the procedure so they can be used for preprocedure risk stratification.

PATIENTS AND METHODS

Using the Mayo Clinic registry, we analyzed 9035 PCIs on 7640 unique patients from January 1, 2000, through April 30, 2005. We included only the first PCI per patient (n=7457). Logistic regression was used to model the calculated risk score and major procedural complications. Separate risk models were made for mortality and major adverse cardiovascular events (MACE) derived solely from baseline and laboratory characteristics. Final risk scores for procedural death, defined as any death during the index hospitalization, and MACE contained the same 7 variables (age, myocardial infarction less than or equal to 24 hours, preprocedural shock, serum creatinine level, left ventricular ejection fraction, congestive heart failure, and peripheral artery disease).

RESULTS

Models had adequate goodness of fit, and areas under the receiver operating characteristic curve were 0.74 and 0.89 for MACE and procedural death, respectively, indicating excellent overall discrimination. The model was robust across many subgroups, including those undergoing elective PCI, those having diabetes mellitus, and elderly patients. Bootstrap analysis indicated that the model was not overfit to the available data set.

CONCLUSION

Before coronary angiography is performed, a risk-scoring system based on 7 variables can be used conveniently to predict cardiovascular complications after PCI. This model may be useful for providing patients with individualized, evidence-based estimates of procedural risk as part of the informed consent process.

摘要

目的

根据手术前可用的临床和实验室变量推导经皮冠状动脉介入治疗(PCI)结果的风险模型,以便将其用于术前风险分层。

患者与方法

利用梅奥诊所登记处的数据,我们分析了2000年1月1日至2005年4月30日期间7640例独特患者的9035例PCI手术。我们仅纳入每位患者的首次PCI手术(n = 7457)。采用逻辑回归对计算出的风险评分和主要手术并发症进行建模。分别建立仅基于基线和实验室特征的死亡率和主要不良心血管事件(MACE)风险模型。将指数住院期间的任何死亡定义为手术死亡,其最终风险评分和MACE包含相同的7个变量(年龄、小于或等于24小时的心肌梗死、术前休克、血清肌酐水平、左心室射血分数、充血性心力衰竭和外周动脉疾病)。

结果

模型具有良好的拟合优度,MACE和手术死亡的受试者工作特征曲线下面积分别为0.74和0.89,表明总体区分度良好。该模型在许多亚组中都很稳健,包括接受择期PCI的患者、糖尿病患者和老年患者。自助法分析表明该模型对可用数据集没有过度拟合。

结论

在进行冠状动脉造影之前,基于7个变量的风险评分系统可方便地用于预测PCI术后的心血管并发症。作为知情同意过程的一部分,该模型可能有助于为患者提供个体化的、基于证据的手术风险评估。

相似文献

1
Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores.经皮冠状动脉介入治疗风险的床旁评估:新的梅奥诊所风险评分
Mayo Clin Proc. 2007 Jun;82(6):701-8. doi: 10.4065/82.6.701.
2
Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the national cardiovascular data registry.使用国家心血管数据注册中心验证梅奥诊所经皮冠状动脉介入治疗住院死亡率风险评分。
Circ Cardiovasc Interv. 2008 Aug;1(1):36-44. doi: 10.1161/CIRCINTERVENTIONS.107.755991.
3
Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery.经皮冠状动脉介入治疗的梅奥诊所风险评分可预测接受冠状动脉旁路移植术患者的住院死亡率。
Circulation. 2008 Jan 22;117(3):356-62. doi: 10.1161/CIRCULATIONAHA.107.711523. Epub 2008 Jan 2.
4
Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry.利用美国国立心肺血液研究所动态注册数据库对梅奥诊所经皮冠状动脉介入治疗后院内并发症风险调整模型进行验证
J Am Coll Cardiol. 2003 Nov 19;42(10):1722-8. doi: 10.1016/j.jacc.2003.05.007.
5
Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score.经皮冠状动脉介入治疗后主要不良心脏事件的预测:德州心脏研究所风险评分
Am Heart J. 2008 Jun;155(6):1068-74. doi: 10.1016/j.ahj.2008.01.034. Epub 2008 Apr 3.
6
Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).ST 段抬高型急性心肌梗死后行直接经皮冠状动脉介入治疗患者的心血管死亡率和心力衰竭风险评分(来自莱顿 MISSION!梗死登记研究的数据)。
Am J Cardiol. 2012 Jan 15;109(2):187-94. doi: 10.1016/j.amjcard.2011.08.029.
7
Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England.英格兰西北部9914例经皮冠状动脉介入治疗后主要不良心脏事件的多变量预测
Heart. 2006 May;92(5):658-63. doi: 10.1136/hrt.2005.066415. Epub 2005 Sep 13.
8
Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).三个年龄组(<60岁、60至80岁和>80岁)患者经皮冠状动脉介入治疗结果的比较(来自纽约州血管成形术登记处)。
Am J Cardiol. 2006 Nov 15;98(10):1334-9. doi: 10.1016/j.amjcard.2006.06.026. Epub 2006 Sep 28.
9
A novel percutaneous coronary intervention risk score to predict one-year mortality.一种新型经皮冠状动脉介入治疗风险评分预测一年死亡率。
Am J Cardiol. 2010 Sep 1;106(5):641-5. doi: 10.1016/j.amjcard.2010.04.011.
10
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.经皮冠状动脉介入治疗患者长期风险分层的解剖学和临床综合因素:Logistic 临床 SYNTAX 评分。
Eur Heart J. 2012 Dec;33(24):3098-104. doi: 10.1093/eurheartj/ehs295. Epub 2012 Oct 9.

引用本文的文献

1
Automated Real-Time Percutaneous Coronary Intervention Risk Model Leveraging Electronic Health Records.利用电子健康记录的自动实时经皮冠状动脉介入治疗风险模型
JACC Adv. 2025 Jun 25;4(7):101865. doi: 10.1016/j.jacadv.2025.101865.
2
Development and validation of machine learning-derived frailty index in predicting outcomes of patients undergoing percutaneous coronary intervention.机器学习衍生的衰弱指数在预测经皮冠状动脉介入治疗患者结局中的开发与验证
Int J Cardiol Heart Vasc. 2024 Sep 21;55:101511. doi: 10.1016/j.ijcha.2024.101511. eCollection 2024 Dec.
3
Machine learning approaches for risk prediction after percutaneous coronary intervention: a systematic review and meta-analysis.
经皮冠状动脉介入治疗后风险预测的机器学习方法:系统评价与荟萃分析
Eur Heart J Digit Health. 2024 Oct 14;6(1):23-44. doi: 10.1093/ehjdh/ztae074. eCollection 2025 Jan.
4
Fragile hearts: Unveiling the crucial layers of frailty in elderly patients undergoing percutaneous coronary interventions.脆弱的心脏:揭示接受经皮冠状动脉介入治疗的老年患者脆弱性的关键层面。
World J Clin Cases. 2024 Sep 16;12(26):5998-6000. doi: 10.12998/wjcc.v12.i26.5998.
5
Prognostic Value of Preoperative Assessment of Left Ventricular Function in Patients Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗患者术前左心室功能评估的预后价值
Rev Cardiovasc Med. 2023 Mar 6;24(3):80. doi: 10.31083/j.rcm2403080. eCollection 2023 Mar.
6
Development and validation of a nomogram predicting one-year mortality in patients undergoing percutaneous coronary intervention.预测接受经皮冠状动脉介入治疗患者一年死亡率的列线图的开发与验证
J Geriatr Cardiol. 2022 Dec 28;19(12):960-969. doi: 10.11909/j.issn.1671-5411.2022.12.003.
7
A nomogram predicting 30-day mortality in patients undergoing percutaneous coronary intervention.一种预测接受经皮冠状动脉介入治疗患者30天死亡率的列线图。
Front Cardiovasc Med. 2022 Aug 17;9:897020. doi: 10.3389/fcvm.2022.897020. eCollection 2022.
8
Current and Future Applications of Artificial Intelligence in Coronary Artery Disease.人工智能在冠状动脉疾病中的当前及未来应用
Healthcare (Basel). 2022 Jan 26;10(2):232. doi: 10.3390/healthcare10020232.
9
Application of machine learning to predict the occurrence of arrhythmia after acute myocardial infarction.机器学习在预测急性心肌梗死后心律失常发生中的应用。
BMC Med Inform Decis Mak. 2021 Nov 2;21(1):301. doi: 10.1186/s12911-021-01667-8.
10
Percutaneous Coronary Intervention Outcomes Based on Decision-Making Capacity.基于决策能力的经皮冠状动脉介入治疗结局。
J Am Heart Assoc. 2021 Sep 7;10(17):e020609. doi: 10.1161/JAHA.120.020609. Epub 2021 Aug 28.